IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q4 2018 Holdings

Filed 2019-02-12 | 3 holdings | $103.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aegerion Pharmaceuticals IncNOTE 2.000% 8/100767EAB8$89.2K$117,737,00085.9%
PTC Therapeutics IncNOTE 3.000% 8/169366JAB7$8.1K$8,067,0007.8%
Kala Pharmaceuticals IncCOM483119103$6.5K1,333,3336.3%